Crossmark

Identifying patients with undiagnosed small intestinal neuroendocrine tumours in primary care using statistical and machine learning: model development and validation study

Crossref DOI link: https://doi.org/10.1038/s41416-024-02736-1

Published Online: 2024-06-03

Published Print: 2024-07-22

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Clift, Ash Kieran https://orcid.org/0000-0002-0061-979X
Mahon, Hadley

Khan, Ghazanfar

Boardman-Pretty, Freya

Worker, Amanda

Marchini, Elena

Buendia, Orlando

Fish, Peter

Khan, Mohid S.
License Information

Text and Data Mining valid from 2024-06-03

Version of Record valid from 2024-06-03
More Information

Article History

Received: 26 July 2023

Revised: 10 May 2024

Accepted: 23 May 2024

First Online: 3 June 2024

Competing interests

: During the study conduct, AKC, HM, GK, FB-P, AW, EM, OB and PF were employees of Mendelian. MK reports consultancy fees from Advanced Accelerator Applications (a Novartis company), BMS, Ipsen, Mendelian, and Novartis.

: Ethical approval for the OPCRD database for clinical research purposes has been obtained from the NHS Health Research Authority (REC reference 20/EM/0148). This study was approved by the ADEPT committee (reference: PROTOCOL2318).

Document is current

Any future updates will be listed below